Novartis AG in Consumer Health (World)

Date: September 25, 2013
Pages: 33
US$ 572.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: NC43D06994BEN

Download PDF Leaflet

As one of the world’s largest pharmaceutical companies, Novartis is a global leader in consumer health. However, the company has faced significant manufacturing disruptions that have adversely affected its industry sales. While remediation in the US is gaining traction, Novartis faces significant challenges in re-establishing its leading brands in the world’s largest consumer health market. Globally, its portfolio, though perhaps overly concentrated, continues to perform well.

Euromonitor International’s Novartis AG in Consumer Health (World) Company Profile offers detailed strategic analysis of the company’s business, examining its performance in the Consumer Health industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Scope of the Report
Strategic Evaluation
Strategic evaluation
Competitive Positioning
Market Assessment
Geographic and Category Opportunities
Brand Strategy
Report Definitions
Skip to top

Bayer AG in Consumer Health (World) US$ 520.00 Nov, 2013 · 33 pages
Bristol-Myers Squibb Co in Consumer Health (World) US$ 520.00 Feb, 2013 · 32 pages
Herbalife Ltd in Consumer Health (World) US$ 572.00 Mar, 2013 · 29 pages
Johnson & Johnson Inc in Consumer Health (World) US$ 572.00 Jul, 2015 · 37 pages
Merck & Co Inc in Consumer Health (World) US$ 572.00 Jul, 2013 · 33 pages

Ask Your Question

Novartis AG in Consumer Health (World)
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: